Relationship between patient's risk profile and benefits in mortality from adjunctive abciximab to mechanical revascularization for ST-segment elevation myocardial infarction: a meta-regression analysis of randomized trials.
Publication
, Journal Article
De Luca, G; Suryapranata, H; Stone, GW; Antoniucci, D; Tcheng, JE; Neumann, F-J; Bonizzoni, E; Topol, EJ; Chiariello, M
Published in: J Am Coll Cardiol
February 7, 2006
Duke Scholars
Published In
J Am Coll Cardiol
DOI
EISSN
1558-3597
Publication Date
February 7, 2006
Volume
47
Issue
3
Start / End Page
685 / 686
Location
United States
Related Subject Headings
- Survival Rate
- Risk Factors
- Randomized Controlled Trials as Topic
- Platelet Glycoprotein GPIIb-IIIa Complex
- Platelet Aggregation Inhibitors
- Myocardial Infarction
- Immunoglobulin Fab Fragments
- Humans
- Electrocardiography
- Combined Modality Therapy
Citation
APA
Chicago
ICMJE
MLA
NLM
De Luca, G., Suryapranata, H., Stone, G. W., Antoniucci, D., Tcheng, J. E., Neumann, F.-J., … Chiariello, M. (2006). Relationship between patient's risk profile and benefits in mortality from adjunctive abciximab to mechanical revascularization for ST-segment elevation myocardial infarction: a meta-regression analysis of randomized trials. J Am Coll Cardiol, 47(3), 685–686. https://doi.org/10.1016/j.jacc.2005.11.018
De Luca, Giuseppe, Harry Suryapranata, Gregg W. Stone, David Antoniucci, James E. Tcheng, Franz-Josef Neumann, Erminio Bonizzoni, Eric J. Topol, and Massimo Chiariello. “Relationship between patient's risk profile and benefits in mortality from adjunctive abciximab to mechanical revascularization for ST-segment elevation myocardial infarction: a meta-regression analysis of randomized trials.” J Am Coll Cardiol 47, no. 3 (February 7, 2006): 685–86. https://doi.org/10.1016/j.jacc.2005.11.018.
De Luca G, Suryapranata H, Stone GW, Antoniucci D, Tcheng JE, Neumann F-J, et al. Relationship between patient's risk profile and benefits in mortality from adjunctive abciximab to mechanical revascularization for ST-segment elevation myocardial infarction: a meta-regression analysis of randomized trials. J Am Coll Cardiol. 2006 Feb 7;47(3):685–6.
De Luca, Giuseppe, et al. “Relationship between patient's risk profile and benefits in mortality from adjunctive abciximab to mechanical revascularization for ST-segment elevation myocardial infarction: a meta-regression analysis of randomized trials.” J Am Coll Cardiol, vol. 47, no. 3, Feb. 2006, pp. 685–86. Pubmed, doi:10.1016/j.jacc.2005.11.018.
De Luca G, Suryapranata H, Stone GW, Antoniucci D, Tcheng JE, Neumann F-J, Bonizzoni E, Topol EJ, Chiariello M. Relationship between patient's risk profile and benefits in mortality from adjunctive abciximab to mechanical revascularization for ST-segment elevation myocardial infarction: a meta-regression analysis of randomized trials. J Am Coll Cardiol. 2006 Feb 7;47(3):685–686.
Published In
J Am Coll Cardiol
DOI
EISSN
1558-3597
Publication Date
February 7, 2006
Volume
47
Issue
3
Start / End Page
685 / 686
Location
United States
Related Subject Headings
- Survival Rate
- Risk Factors
- Randomized Controlled Trials as Topic
- Platelet Glycoprotein GPIIb-IIIa Complex
- Platelet Aggregation Inhibitors
- Myocardial Infarction
- Immunoglobulin Fab Fragments
- Humans
- Electrocardiography
- Combined Modality Therapy